Kaufmann W K, Kies P E
Department of Pathology and Laboratory Medicine, Curriculum in Toxicology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill 27599-7295, USA.
Mutat Res. 1998 May 25;400(1-2):153-67. doi: 10.1016/s0027-5107(98)00041-4.
DNA (deoxyribonucleic acid) signals that induce the G2 checkpoint response were examined using proliferative secondary cultures of diploid human fibroblasts. Treatments that generated DNA double-strand breaks (DSBs) directly were effective inducers of checkpoint response, generally producing >80% inhibition of mitosis (G2 delay) and the kinase activity of M-phase-promoting factor within 2 h of treatment. Effective inducers of G2 checkpoint response included gamma-irradiation and the cancer chemotherapeutic drugs, bleomycin and etoposide. Treatments that produced DNA single-strand breaks, directly or indirectly through nucleotide excision repair, were not effective inducers of G2 delay. Ineffective treatments included incubation with camptothecin, an inhibitor of topoisomerase I (topo I), and irradiation with sublethal fluences of UVC, followed by incubation with aphidicolin. Transient severe inhibition of DNA synthesis with aphidicolin did not affect mitosis substantially, suggesting that the replication arrest input to the G2 checkpoint required more than brief inhibition of DNA synthesis. In contrast, moderate camptothecin-induced inhibition of DNA synthesis was associated with a strong inhibition of mitosis that developed 4-12 h after drug treatment. This result suggested that G2 delay was not expressed until the cells that were in S-phase at the time of treatment with camptothecin proceeded into G2. DNA damage was not necessary for induction of mitotic delay. An inhibitor of topoisomerase II (topo II), ICRF-193, which inhibits chromatid decatenation in G2 cells without damaging DNA, induced a severe inhibition of mitosis and M-phase-promoting factor kinase activity. The results suggest that DNA double-strand breaks and insufficiency of chromatid decatenation effectively induce the G2 checkpoint response, but DNA single-strand breaks do not.
利用二倍体人成纤维细胞的增殖性传代培养物,研究了诱导G2期检查点反应的DNA(脱氧核糖核酸)信号。直接产生DNA双链断裂(DSB)的处理方法是检查点反应的有效诱导剂,通常在处理后2小时内可使有丝分裂受到>80%的抑制(G2期延迟),并抑制M期促进因子的激酶活性。G2期检查点反应的有效诱导剂包括γ射线照射以及癌症化疗药物博来霉素和依托泊苷。直接或通过核苷酸切除修复间接产生DNA单链断裂的处理方法,不是G2期延迟的有效诱导剂。无效的处理方法包括与拓扑异构酶I(拓扑酶I)抑制剂喜树碱孵育,以及用亚致死剂量的紫外线C照射,随后与阿非迪霉素孵育。用阿非迪霉素短暂严重抑制DNA合成对有丝分裂基本没有影响,这表明输入到G2期检查点的复制停滞需要的不仅仅是对DNA合成的短暂抑制。相比之下,喜树碱诱导的适度DNA合成抑制与药物处理后4 - 12小时出现的强烈有丝分裂抑制有关。这一结果表明,直到用喜树碱处理时处于S期的细胞进入G2期,G2期延迟才会表现出来。诱导有丝分裂延迟并不一定需要DNA损伤。拓扑异构酶II(拓扑酶II)抑制剂ICRF - 193可抑制G2期细胞中的染色单体解连环而不损伤DNA,它能严重抑制有丝分裂和M期促进因子激酶活性。结果表明,DNA双链断裂和染色单体解连环不足可有效诱导G2期检查点反应,但DNA单链断裂则不能。